Javascript must be enabled to continue!
Cardiodepressant mediators are released after myocardial ischaemia: modulation by catecholamines and adenosine
View through CrossRef
The interaction of recently characterized cardiodepressant mediators with catecholamines and adenosine after myocardial ischaemia was investigated using a model of sequential perfusion of two isolated guinea‐pig hearts. Sequential perfusion was initiated after 10, 20, and 30 min (group I, II, and III) of global ischaemia in the first heart. At the onset of sequential perfusion LVdP/dtmax and min of Heart II decreased by 46 and 44% in group I, by 28 and 34% in group II, and increased by 60 and 24% in group III. Infusion of the β1‐receptor antagonist metoprolol (2.8 μmol L–1) into Heart II did not modulate contractile changes after 10 min of ischaemia in Heart I, prevented the attenuation of the cardiodepressant effect after 20 min of ischaemia, and completely reversed the positive inotropic effect after 30 min of ischaemia. The A1‐ and A2‐receptor antagonists DPCPX (2 μmol L–1) and DMPX (20 μmol L–1) enhanced the positive inotropic and lusitropic effects in Heart II (LVdP/dtmax +154%, LVdP/dtmin +71%) during sequential perfusion after 30 min of ischaemia in Heart I. It is concluded that the effects of cardiodepressant mediators released after myocardial ischaemia are counteracted by a time‐dependent release of catecholamines. Endogenous cardiac adenosine, in turn, attenuates the modulatory effects of catecholamines.
Title: Cardiodepressant mediators are released after myocardial ischaemia: modulation by catecholamines and adenosine
Description:
The interaction of recently characterized cardiodepressant mediators with catecholamines and adenosine after myocardial ischaemia was investigated using a model of sequential perfusion of two isolated guinea‐pig hearts.
Sequential perfusion was initiated after 10, 20, and 30 min (group I, II, and III) of global ischaemia in the first heart.
At the onset of sequential perfusion LVdP/dtmax and min of Heart II decreased by 46 and 44% in group I, by 28 and 34% in group II, and increased by 60 and 24% in group III.
Infusion of the β1‐receptor antagonist metoprolol (2.
8 μmol L–1) into Heart II did not modulate contractile changes after 10 min of ischaemia in Heart I, prevented the attenuation of the cardiodepressant effect after 20 min of ischaemia, and completely reversed the positive inotropic effect after 30 min of ischaemia.
The A1‐ and A2‐receptor antagonists DPCPX (2 μmol L–1) and DMPX (20 μmol L–1) enhanced the positive inotropic and lusitropic effects in Heart II (LVdP/dtmax +154%, LVdP/dtmin +71%) during sequential perfusion after 30 min of ischaemia in Heart I.
It is concluded that the effects of cardiodepressant mediators released after myocardial ischaemia are counteracted by a time‐dependent release of catecholamines.
Endogenous cardiac adenosine, in turn, attenuates the modulatory effects of catecholamines.
Related Results
e0106 The effect of adenosine and ischaemia postconditioning on MMP-2 and MMP-9 in rabbit ischaemia reperfusion myocardial
e0106 The effect of adenosine and ischaemia postconditioning on MMP-2 and MMP-9 in rabbit ischaemia reperfusion myocardial
Objective
To observe the effect of adenosine and ischaemia postconditioning on MMP-2 and MMP-9 in rabbit ischaemia reperfusion myocardial.
...
GW24-e3040 The influence of rosiglitazone on the expression of TNF-a and CX43 in dogs of chronic myocardial ischaemia
GW24-e3040 The influence of rosiglitazone on the expression of TNF-a and CX43 in dogs of chronic myocardial ischaemia
Objectives
To observe the effects of rosiglitazone on myocardial fibrosis of chronic myocardial ischaemia in dogs.
...
Analgesic effects of adenosine in Syndrome X are counteracted by theophylline: a double-blind placebo-controlled study
Analgesic effects of adenosine in Syndrome X are counteracted by theophylline: a double-blind placebo-controlled study
It has been proposed that adenosine mediates ischaemic pain in humans. Patients with cardiac Syndrome X are hypersensitive to potential pain stimuli, including adenosine. On the ot...
e0141 The effects and mechanisms between DIDS and EDRV on acute ischaemia-reperfusion injury myocardium
e0141 The effects and mechanisms between DIDS and EDRV on acute ischaemia-reperfusion injury myocardium
Aim
To investigate the effects and Mechanisms of chloride channel inhibitor, 4, 4′- Diisothiocyanostilbene-2, 2′- disulfonic acid (DIDS) and free radical scavenge...
Adrenergic modulation of human polymorphonuclear leukocyte activation. Potentiating effect of adenosine
Adrenergic modulation of human polymorphonuclear leukocyte activation. Potentiating effect of adenosine
Abstract
The activation of polymorphonuclear leukocytes (PMN) is an important step in the development of tissue damage associated with inflammatory and ischemic cond...
Role and Regulation Of Erythrocyte Sphingosine Kinase 1 Activity In Normal and Sickle Cell Disease
Role and Regulation Of Erythrocyte Sphingosine Kinase 1 Activity In Normal and Sickle Cell Disease
Abstract
Sickle Cell Disease (SCD) is a devastating genetic disorder attacking red blood cells (RBCs) and affecting millions of humans worldwide. The Glu/Val mutatio...
e0028 The effect of acute activation of ALDH2 on myocardial ischaemia/reperfusion injury in rat
e0028 The effect of acute activation of ALDH2 on myocardial ischaemia/reperfusion injury in rat
Background
Our previous study combined several animal experiments conducted recently showed aldehyde dehydrogenase-2 (ALDH2) was correlated with myocardial ischae...
e0618 Effects of Rosuvastatin on plasma NO and ET-1 during myocardial ischaemia-reperfusion injury in rabbits
e0618 Effects of Rosuvastatin on plasma NO and ET-1 during myocardial ischaemia-reperfusion injury in rabbits
Objective
To study the change of endothelial function during myocardial ischaemia-reperfusion injury in rabbits and the effect of Rosuvastatin.
...

